Ening adverse events, including severe infections and malignancies, ruxolitinib discontinuation syndrome, and Wernicke's encephalopathy.403,406,407,431 Fifth,
Ening adverse events, including severe infections and malignancies, ruxolitinib discontinuation syndrome, and Wernicke’s encephalopathy.403,406,407,431...